skin disease: Stevens-Johnson Syndrome(SJS) Toxic Epidermal Necrolysis(TEN) Erythema Multiforme major(EM major) Staphylococcal Scalded Skin Syndrome(SSSS) Toxicodermia fixed drug eruption Drug-induced hypersensitivity syndrome(DIHS) impetigo contagiosa Acute Generalized Exanthematous Pustulosis(AGEP) paraneoplastic pemphigus
Conditions
Interventions
None listed
Sponsors
Department of Drug Development and Regulatory Science, Faculty of Pharmacy, Keio University
Department of Dermatology, Faculty of Medicine, Keio University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with diseases specified in Condition.
Exclusion criteria
Exclusion criteria: Patients concomitantly affected with SJS/TEN and DIHS.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity, specificity and positive predictive value(PPV) | — |
Countries
Japan
Contacts
Public ContactHisashi Urushihara
Faculty of Pharmacy, Keio University Department of Drug Development and Regulatory Science
Outcome results
None listed